KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Long-Term Investments (2016 - 2026)

Quest Diagnostics' Long-Term Investments history spans 13 years, with the latest figure at $134.0 million for Q1 2026.

  • On a quarterly basis, Long-Term Investments changed 0.0% to $134.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $134.0 million, a 0.0% change, with the full-year FY2025 number at $136.0 million, up 10.57% from a year prior.
  • Long-Term Investments hit $134.0 million in Q1 2026 for Quest Diagnostics, down from $136.0 million in the prior quarter.
  • Over the last five years, Long-Term Investments for DGX hit a ceiling of $155.0 million in Q1 2022 and a floor of $123.0 million in Q4 2024.
  • Historically, Long-Term Investments has averaged $134.4 million across 5 years, with a median of $134.0 million in 2025.
  • The widest YoY moves for Long-Term Investments: up 32.43% in 2022, down 70.59% in 2022.
  • Tracing DGX's Long-Term Investments over 5 years: stood at $132.0 million in 2022, then increased by 2.27% to $135.0 million in 2023, then decreased by 8.89% to $123.0 million in 2024, then increased by 10.57% to $136.0 million in 2025, then fell by 1.47% to $134.0 million in 2026.
  • Business Quant data shows Long-Term Investments for DGX at $134.0 million in Q1 2026, $136.0 million in Q4 2025, and $137.0 million in Q3 2025.